Systematic review and meta-analysis of human milk intake and retinopathy of prematurity

A significant update

S. K. Bharwani, B. F. Green, J. C. Pezzullo, S. S. Bharwani, S. S. Bharwani, Ramasubbareddy Dhanireddy

Research output: Contribution to journalReview article

16 Citations (Scopus)

Abstract

OBJECTIVE: Two recent meta-analyses have studied the association of exclusive or mainly human milk intake (HMI) on retinopathy of prematurity (ROP). One of these meta-analysis found a protective effect of only or mainly HMI on Severe ROP but not on any stage ROP. However, both these meta-analyses did not find protection from any stage ROP or Severe ROP with any amount of HMI. The objective of this study was to study the association between any amount of HMI and the development of All ROP and Severe ROP in very-low birth weight infants (VLBWI) and extremely low birth weight infants (ELBWI) by systematic review using PRISMA-P guidelines and meta-analysis. Study design: Exposure, controls and outcomes studied were any amount of HMI vs no HMI and All ROP/Severe ROP in VLBWI/ELBWI. All ROP was defined as all stages of ROP pooled together, and Severe ROP as ≥stage 3 ROP and ROP requiring intervention. Results and effect sizes are expressed as odds ratio (OR), relative risk (RR), risk difference (RD) and number needed to treat (NNT) with 95% confidence intervals (95% CI). Data sources used were PubMed, MEDLINE, EMBASE, Cochrane Central Register of Clinical Trials, Scopus and CINAHL until 24 April 2015. Extracted data were pooled using a fixed effects model. Heterogeneity was assessed. Sensitivity analysis was performed. Results: Five hundred nine of 1701 infants who received any amount of HMI developed All ROP vs 310 of 760 infants without HMI developed All ROP with a pooled OR 0.63∗ (0.51,0.78), RR 0.76∗ (0.67,0.86) and RD -0.09∗ (-0.13,-0.05). The NNT with any amount of HMI was 11∗ (8,20) (∗P<0.0001) to prevent one case of All ROP. 204 of 2465 infants who received any amount of HMI developed Severe ROP vs 85 of 764 infants without HMI developed Severe ROP with a pooled OR 0.74∗ (0.56,0.98), RR 0.77∗ (0.60,0.98) and RD -0.03∗ (-0.05,-0.00). The NNT with any amount of HMI was 33∗ (∗P=0.04) to prevent one case of Severe ROP. Conclusion: Any amount of HMI is strongly associated with the protection from All ROP and Severe ROP.

Original languageEnglish (US)
Pages (from-to)913-920
Number of pages8
JournalJournal of Perinatology
Volume36
Issue number11
DOIs
StatePublished - Nov 1 2016

Fingerprint

Retinopathy of Prematurity
Human Milk
Meta-Analysis
Numbers Needed To Treat
Extremely Low Birth Weight Infant
Very Low Birth Weight Infant
Odds Ratio

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology

Cite this

Systematic review and meta-analysis of human milk intake and retinopathy of prematurity : A significant update. / Bharwani, S. K.; Green, B. F.; Pezzullo, J. C.; Bharwani, S. S.; Bharwani, S. S.; Dhanireddy, Ramasubbareddy.

In: Journal of Perinatology, Vol. 36, No. 11, 01.11.2016, p. 913-920.

Research output: Contribution to journalReview article

Bharwani, S. K. ; Green, B. F. ; Pezzullo, J. C. ; Bharwani, S. S. ; Bharwani, S. S. ; Dhanireddy, Ramasubbareddy. / Systematic review and meta-analysis of human milk intake and retinopathy of prematurity : A significant update. In: Journal of Perinatology. 2016 ; Vol. 36, No. 11. pp. 913-920.
@article{fc7e6f3a1fff4e7cbff190c070995712,
title = "Systematic review and meta-analysis of human milk intake and retinopathy of prematurity: A significant update",
abstract = "OBJECTIVE: Two recent meta-analyses have studied the association of exclusive or mainly human milk intake (HMI) on retinopathy of prematurity (ROP). One of these meta-analysis found a protective effect of only or mainly HMI on Severe ROP but not on any stage ROP. However, both these meta-analyses did not find protection from any stage ROP or Severe ROP with any amount of HMI. The objective of this study was to study the association between any amount of HMI and the development of All ROP and Severe ROP in very-low birth weight infants (VLBWI) and extremely low birth weight infants (ELBWI) by systematic review using PRISMA-P guidelines and meta-analysis. Study design: Exposure, controls and outcomes studied were any amount of HMI vs no HMI and All ROP/Severe ROP in VLBWI/ELBWI. All ROP was defined as all stages of ROP pooled together, and Severe ROP as ≥stage 3 ROP and ROP requiring intervention. Results and effect sizes are expressed as odds ratio (OR), relative risk (RR), risk difference (RD) and number needed to treat (NNT) with 95{\%} confidence intervals (95{\%} CI). Data sources used were PubMed, MEDLINE, EMBASE, Cochrane Central Register of Clinical Trials, Scopus and CINAHL until 24 April 2015. Extracted data were pooled using a fixed effects model. Heterogeneity was assessed. Sensitivity analysis was performed. Results: Five hundred nine of 1701 infants who received any amount of HMI developed All ROP vs 310 of 760 infants without HMI developed All ROP with a pooled OR 0.63∗ (0.51,0.78), RR 0.76∗ (0.67,0.86) and RD -0.09∗ (-0.13,-0.05). The NNT with any amount of HMI was 11∗ (8,20) (∗P<0.0001) to prevent one case of All ROP. 204 of 2465 infants who received any amount of HMI developed Severe ROP vs 85 of 764 infants without HMI developed Severe ROP with a pooled OR 0.74∗ (0.56,0.98), RR 0.77∗ (0.60,0.98) and RD -0.03∗ (-0.05,-0.00). The NNT with any amount of HMI was 33∗ (∗P=0.04) to prevent one case of Severe ROP. Conclusion: Any amount of HMI is strongly associated with the protection from All ROP and Severe ROP.",
author = "Bharwani, {S. K.} and Green, {B. F.} and Pezzullo, {J. C.} and Bharwani, {S. S.} and Bharwani, {S. S.} and Ramasubbareddy Dhanireddy",
year = "2016",
month = "11",
day = "1",
doi = "10.1038/jp.2016.98",
language = "English (US)",
volume = "36",
pages = "913--920",
journal = "Journal of Perinatology",
issn = "0743-8346",
publisher = "Nature Publishing Group",
number = "11",

}

TY - JOUR

T1 - Systematic review and meta-analysis of human milk intake and retinopathy of prematurity

T2 - A significant update

AU - Bharwani, S. K.

AU - Green, B. F.

AU - Pezzullo, J. C.

AU - Bharwani, S. S.

AU - Bharwani, S. S.

AU - Dhanireddy, Ramasubbareddy

PY - 2016/11/1

Y1 - 2016/11/1

N2 - OBJECTIVE: Two recent meta-analyses have studied the association of exclusive or mainly human milk intake (HMI) on retinopathy of prematurity (ROP). One of these meta-analysis found a protective effect of only or mainly HMI on Severe ROP but not on any stage ROP. However, both these meta-analyses did not find protection from any stage ROP or Severe ROP with any amount of HMI. The objective of this study was to study the association between any amount of HMI and the development of All ROP and Severe ROP in very-low birth weight infants (VLBWI) and extremely low birth weight infants (ELBWI) by systematic review using PRISMA-P guidelines and meta-analysis. Study design: Exposure, controls and outcomes studied were any amount of HMI vs no HMI and All ROP/Severe ROP in VLBWI/ELBWI. All ROP was defined as all stages of ROP pooled together, and Severe ROP as ≥stage 3 ROP and ROP requiring intervention. Results and effect sizes are expressed as odds ratio (OR), relative risk (RR), risk difference (RD) and number needed to treat (NNT) with 95% confidence intervals (95% CI). Data sources used were PubMed, MEDLINE, EMBASE, Cochrane Central Register of Clinical Trials, Scopus and CINAHL until 24 April 2015. Extracted data were pooled using a fixed effects model. Heterogeneity was assessed. Sensitivity analysis was performed. Results: Five hundred nine of 1701 infants who received any amount of HMI developed All ROP vs 310 of 760 infants without HMI developed All ROP with a pooled OR 0.63∗ (0.51,0.78), RR 0.76∗ (0.67,0.86) and RD -0.09∗ (-0.13,-0.05). The NNT with any amount of HMI was 11∗ (8,20) (∗P<0.0001) to prevent one case of All ROP. 204 of 2465 infants who received any amount of HMI developed Severe ROP vs 85 of 764 infants without HMI developed Severe ROP with a pooled OR 0.74∗ (0.56,0.98), RR 0.77∗ (0.60,0.98) and RD -0.03∗ (-0.05,-0.00). The NNT with any amount of HMI was 33∗ (∗P=0.04) to prevent one case of Severe ROP. Conclusion: Any amount of HMI is strongly associated with the protection from All ROP and Severe ROP.

AB - OBJECTIVE: Two recent meta-analyses have studied the association of exclusive or mainly human milk intake (HMI) on retinopathy of prematurity (ROP). One of these meta-analysis found a protective effect of only or mainly HMI on Severe ROP but not on any stage ROP. However, both these meta-analyses did not find protection from any stage ROP or Severe ROP with any amount of HMI. The objective of this study was to study the association between any amount of HMI and the development of All ROP and Severe ROP in very-low birth weight infants (VLBWI) and extremely low birth weight infants (ELBWI) by systematic review using PRISMA-P guidelines and meta-analysis. Study design: Exposure, controls and outcomes studied were any amount of HMI vs no HMI and All ROP/Severe ROP in VLBWI/ELBWI. All ROP was defined as all stages of ROP pooled together, and Severe ROP as ≥stage 3 ROP and ROP requiring intervention. Results and effect sizes are expressed as odds ratio (OR), relative risk (RR), risk difference (RD) and number needed to treat (NNT) with 95% confidence intervals (95% CI). Data sources used were PubMed, MEDLINE, EMBASE, Cochrane Central Register of Clinical Trials, Scopus and CINAHL until 24 April 2015. Extracted data were pooled using a fixed effects model. Heterogeneity was assessed. Sensitivity analysis was performed. Results: Five hundred nine of 1701 infants who received any amount of HMI developed All ROP vs 310 of 760 infants without HMI developed All ROP with a pooled OR 0.63∗ (0.51,0.78), RR 0.76∗ (0.67,0.86) and RD -0.09∗ (-0.13,-0.05). The NNT with any amount of HMI was 11∗ (8,20) (∗P<0.0001) to prevent one case of All ROP. 204 of 2465 infants who received any amount of HMI developed Severe ROP vs 85 of 764 infants without HMI developed Severe ROP with a pooled OR 0.74∗ (0.56,0.98), RR 0.77∗ (0.60,0.98) and RD -0.03∗ (-0.05,-0.00). The NNT with any amount of HMI was 33∗ (∗P=0.04) to prevent one case of Severe ROP. Conclusion: Any amount of HMI is strongly associated with the protection from All ROP and Severe ROP.

UR - http://www.scopus.com/inward/record.url?scp=84978523940&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84978523940&partnerID=8YFLogxK

U2 - 10.1038/jp.2016.98

DO - 10.1038/jp.2016.98

M3 - Review article

VL - 36

SP - 913

EP - 920

JO - Journal of Perinatology

JF - Journal of Perinatology

SN - 0743-8346

IS - 11

ER -